The startup provides outpatient laboratory services through PCR-based molecular diagnostics tests that detect infectious agents in clinical samples. This enables physicians to achieve rapid diagnoses for the majority of outpatient sick visits within hours, enhancing patient care efficiency.
Funding
$940K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
In outpatient settings, accurately and quickly diagnosing infections can be challenging due to overlapping symptoms and the time required for traditional laboratory testing. Delayed results can lead to unnecessary treatments, prolonged illness, and increased healthcare costs.
Solution
Magnolia Diagnostics offers rapid PCR-based molecular diagnostic testing services for the detection of infectious agents in clinical samples. By providing results within hours, Magnolia Diagnostics enables physicians to make informed decisions during the initial outpatient visit, reducing the need for broad-spectrum treatments and improving patient outcomes. Their comprehensive testing services deliver accurate diagnoses, eliminating the guesswork associated with overlapping symptoms. This leads to more effective treatment plans and a quicker return to health for patients.
Target Audience
The primary customers are healthcare providers in outpatient settings, such as primary care physicians, urgent care centers, and specialist clinics.
Features
- PCR-based molecular diagnostics for rapid detection of infectious agents
- Comprehensive testing menu covering a wide range of common infections
- Results available within hours to facilitate timely clinical decision-making
- Online portal for providers to easily order tests and access results